Catheter ablation of primary supraventricular tachycardia substrate presenting as atrial fibrillation in adolescents

Congenital Heart Disease

Volumn 5, Issue 5, 2010, Pages 465-469

  Strieper, Margaret J ^a   Frias, Patrick ^a   Fischbach, Peter ^a   Costello, Lynne ^b   Campbell, Robert M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Atrial Fibrillation; Catheter Ablation; Pediatrics

Indexed keywords

AMIODARONE; ATENOLOL; DIGOXIN; FLECAINIDE;

ADOLESCENT; ARTICLE; CARDIOVERSION; CASE REPORT; CATHETER ABLATION; CLINICAL FEATURE; ELECTROCARDIOGRAPHY MONITORING; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; SUPRAVENTRICULAR TACHYCARDIA;

ADOLESCENT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; RECURRENCE; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 77957128914     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2009.00368.x     Document Type: Article

References (19)

1. Swartz J, Pellersels G, Silvers J, Patten L, Cervantez D. A catheter based curative approach to atrial fibrillation in humans. Circulation. 1994, 90(I):I-335. suppl
2. Haissaguerre M, Jais P, Shah DC. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998, 339:659-666.
3. Pappone C, Rosanio S, Oreto G. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000, 102:2619-2628.
4. Nanthakumar K, Lau YR, Plumb VJ, Epstein AE, Kay NG. Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts. Circulation. 2004, 110:117-123.
5. Radford DJ, Izukawa T. Atrial fibrillation in children. Pediatrics. 1977, 59:250-256.
6. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979, 301:1080-1085.
7. Maron BJ, McKenna WJ, Danielson GK. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
8. Sparks EA, Graber HL, Boudoulas H. Atrial myopathy and atrial fibrillation: phenotypes in heritable cardiac conduction and myocardial disease. Eur Heart J Suppl. 2000, 2:K78-K90.
9. Perry LW, Hung W. Atrial fibrillation and hyperthyroidism in a 14-year-old boy. J Pediatr. 1971, 79:668-671.
10. Benson DW, Silberbach GM, Kavanaugh-McHugh A. Mutations in the cardiac transcription factor NKX2.5 affect development pathways. J Clin Invest 1999, 104:1567-1573.
11. Bigi MAB, Aslani A, Shahrzad S. Clinical predictors of atrial fibrillation in Brugada syndrome. Europace 2007, 9:947-950. eum110v1
12. Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol. 2005, 16:394-396.
13. Laitinen-Forsblom PJ, Mäkynen P, Mäkynen H. SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias. J Cardiovasc Electrophysiol. 2006, 17:480-485.
14. Fuster V, Rydén LE, Cannom DS. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e257-e354.
15. Kay GN, Ellenbogen KA, Giudici M. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Interv Card Electrophysiol. 1998, 2:121-135.
16. Feld GK, Fleck RP, Fujimura O, Prothro DL, Bahnson TD, Ibarra M. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. Circulation. 1994, 90:2299-2307.
17. Cappato R, Calkins H, Chen SA. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005, 111:1100-1105.
18. Karch MR, Zrenner B, Deisenhofer I. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 2005, 111:2875-2880.
19. Chen PS, Pressley JC, Tang AS. New observations on atrial fiblrillation before and after surgery in patients with Wolff-Parkinson, White syndrome. J Cardiovasc Electrophysiol 1998, 9:141-151.